|
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
37 results found
| no | title | author | magazine | year | volume | issue | page(s) | type |
| 1 | Alcohol abuse in the critically ill patient |
Moss, Marc |
2006 |
368 | 9554 |
p. 2231-2242 12 p. |
article |
|
| 2 | A tale of radium, love, and death |
Eagleton, Terry |
2006 |
368 | 9554 |
p. 2201-2202 2 p. |
article |
|
| 3 | Benjamin Jesty: the first vaccinator revealed |
Pead, Patrick J |
2006 |
368 | 9554 |
p. 2202- 1 p. |
article |
|
| 4 | Dementia and white-matter demyelination in young patient with neurosyphilis |
Brinar, Vesna V |
2006 |
368 | 9554 |
p. 2258- 1 p. |
article |
|
| 5 | Dengue: setting the global research agenda |
Kroeger, Axel |
2006 |
368 | 9554 |
p. 2193-2195 3 p. |
article |
|
| 6 | Department of Error |
2006 |
368 | 9554 |
p. 2210- 1 p. |
article |
||
| 7 | Department of Error |
2006 |
368 | 9554 |
p. 2210- 1 p. |
article |
||
| 8 | Developing country trialists are key for malaria vaccine goals |
The Lancet, |
2006 |
368 | 9554 |
p. 2185- 1 p. |
article |
|
| 9 | Esther Miriam Lederberg |
Oransky, Ivan |
2006 |
368 | 9554 |
p. 2204- 1 p. |
article |
|
| 10 | Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis |
Murray, Christopher JL |
2006 |
368 | 9554 |
p. 2211-2218 8 p. |
article |
|
| 11 | Haemoglobin concentrations in chronic kidney disease |
Steinbrook, Robert |
2006 |
368 | 9554 |
p. 2191-2193 3 p. |
article |
|
| 12 | Health reform in Chile |
Letelier, Luz M |
2006 |
368 | 9554 |
p. 2197-2198 2 p. |
article |
|
| 13 | Iain Chalmers: maverick master of medical evidence |
Watts, Geoff |
2006 |
368 | 9554 |
p. 2203- 1 p. |
article |
|
| 14 | Information alongside medicines |
Wilkinson, Emma |
2006 |
368 | 9554 |
p. 2199-2200 2 p. |
article |
|
| 15 | Is Burkitt's lymphoma sexy enough? |
Phillips, John A |
2006 |
368 | 9554 |
p. 2251-2252 2 p. |
article |
|
| 16 | Kofi Annan's positive legacy for health |
The Lancet, |
2006 |
368 | 9554 |
p. 2186- 1 p. |
article |
|
| 17 | Medical response to the 2005 terrorist bombings in London |
Turégano-Fuentes, Fernando |
2006 |
368 | 9554 |
p. 2188-2189 2 p. |
article |
|
| 18 | Mortality of HIV-infected patients in low-income countries |
Kadhiravan, Tamilarasu |
2006 |
368 | 9554 |
p. 2207- 1 p. |
article |
|
| 19 | Mortality of HIV-infected patients in low-income countries – Authors’ response |
Brinkhof, Martin WG |
2006 |
368 | 9554 |
p. 2207-2208 2 p. |
article |
|
| 20 | Oklahoma, OK: emergency preparedness in the USA |
The Lancet, |
2006 |
368 | 9554 |
p. 2186- 1 p. |
article |
|
| 21 | Paracetamol: are therapeutic doses entirely safe? |
Jalan, Rajiv |
2006 |
368 | 9554 |
p. 2195-2196 2 p. |
article |
|
| 22 | Payments for health care in India |
Devadasan, N |
2006 |
368 | 9554 |
p. 2209- 1 p. |
article |
|
| 23 | Poverty and user fees for public health care in low-income countries: lessons from Uganda and Cambodia |
Meessen, Bruno |
2006 |
368 | 9554 |
p. 2253-2257 5 p. |
article |
|
| 24 | Poverty, death, and a future influenza pandemic |
Ferguson, Neil |
2006 |
368 | 9554 |
p. 2187-2188 2 p. |
article |
|
| 25 | Prion reduction filters |
Turner, Marc L |
2006 |
368 | 9554 |
p. 2190-2191 2 p. |
article |
|
| 26 | Reducing inequalities from injuries in Europe |
Sethi, Dinesh |
2006 |
368 | 9554 |
p. 2243-2250 8 p. |
article |
|
| 27 | Reduction in critical mortality in urban mass casualty incidents: analysis of triage, surge, and resource use after the London bombings on July 7, 2005 |
Aylwin, Christopher J |
2006 |
368 | 9554 |
p. 2219-2225 7 p. |
article |
|
| 28 | Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins |
Gregori, Luisa |
2006 |
368 | 9554 |
p. 2226-2230 5 p. |
article |
|
| 29 | Risk in drug trials |
Ohresser, Marc |
2006 |
368 | 9554 |
p. 2205-2206 2 p. |
article |
|
| 30 | Risk in drug trials |
Sugarman, Jeremy |
2006 |
368 | 9554 |
p. 2205- 1 p. |
article |
|
| 31 | Risk in drug trials |
Barnes, Michael R |
2006 |
368 | 9554 |
p. 2205- 1 p. |
article |
|
| 32 | Risk in drug trials |
Focosi, Daniele |
2006 |
368 | 9554 |
p. 2206- 1 p. |
article |
|
| 33 | Safety and immunogenicity of H5N1 vaccine |
Authier, FJ |
2006 |
368 | 9554 |
p. 2209-2210 2 p. |
article |
|
| 34 | Suboptimum use of FDA drug advisory committees |
Tapley, Asa L |
2006 |
368 | 9554 |
p. 2210- 1 p. |
article |
|
| 35 | TGN1412 and The Lancet's solicitation of reports of phase I trials |
Chalmers, Iain |
2006 |
368 | 9554 |
p. 2206-2207 2 p. |
article |
|
| 36 | Varicella in immunocompromised patients |
Vinzio, S |
2006 |
368 | 9554 |
p. 2208- 1 p. |
article |
|
| 37 | Varicella vaccine: local convenience or global equity? |
Durrheim, David N |
2006 |
368 | 9554 |
p. 2208-2209 2 p. |
article |
37 results found